GLENMARK more rally possible

We hold GELNMARK PHARMA (Rs 316) which has come with good results and with brokerages upgrading the stock hold the stock with Rs.300 as Stop loss for Target of Rs.390-400.

Glenmark Pharma Target Raised To INR390 Vs INR320 by Credit Suisse
Glenmark Pharmaceuticals consolidated net profit jumped 38.01% to Rs 111.62 crore on 23.19% increase in total income to Rs 759.54 crore in Q2 September 2010 over Q2 September 2009.
Previous Post - http://akprabhakar.blogspot.com/2010/09/glenmark-near-breakout.html